Immunotherapy Before Surgery Increases Survival in Cutaneous Squamous Cell Carcinoma

Medical science takes a giant leap with a process that sees tumors disappearing or significantly shrinking in 63.3 percent of cutaneous squamous cell carcinoma (CSCC) patients. According to a recent…

Continue Reading Immunotherapy Before Surgery Increases Survival in Cutaneous Squamous Cell Carcinoma
ICYMI: EI-1071 for IPF Earns Orphan Drug Status
Sourced from: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

ICYMI: EI-1071 for IPF Earns Orphan Drug Status

  According to an August 2022 news release from biotechnology company Elixiron Immunotherapeutics (“Elixiron”), EI-1071, a therapy for patients with idiopathic pulmonary fibrosis (IPF), recently earned Orphan Drug designation from…

Continue Reading ICYMI: EI-1071 for IPF Earns Orphan Drug Status
A Biomarker That Detects Alzheimer’s Disease Seventeen Years Before Outward Symptoms Appear
source: pixabay.com

A Biomarker That Detects Alzheimer’s Disease Seventeen Years Before Outward Symptoms Appear

A recent article in SciTechDaily explains that the many failures of newly created Alzheimer’s drugs are the result of clinical plaque tests that do not identify the disease in its…

Continue Reading A Biomarker That Detects Alzheimer’s Disease Seventeen Years Before Outward Symptoms Appear
Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
Source: https://unsplash.com/photos/ZHys6xN7sUE

Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs

  Many patients with ankylosing spondylitis (AS) could be treated with biologics – in particular, biologic disease-modifying antirheumatic drugs (DMARDs). However, this line of treatment is not efficacious nor well-tolerated…

Continue Reading Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
New Data Available on Paltusotine for Acromegaly
source: unsplash.com

New Data Available on Paltusotine for Acromegaly

  On September 9, 2022, researchers presented data at the European Neuroendocrine Association (ENEA) meeting. According to Yahoo! Finance, one such presentation centered around new safety and efficacy data from the…

Continue Reading New Data Available on Paltusotine for Acromegaly